Clinical Trials Logo

Clinical Trial Summary

The aim of this randomized prospective trial is to assess the utility of Adequacy of Anaesthesia technique (Response Entropy and Surgical Pleth Index) for monitoring pain perception intraoperatively and its influence on postoperative pain perception, both patients' and operators' satisfaction in patients undergoing colonoscopic procedures under intravenous sedation using propofol and fentanyl.


Clinical Trial Description

Surgical Pleth Index (SPI) is reported to properly reflect nociception-antinociception balance in patients undergoing surgical procedures, where a value of 100 corresponds to a high stress level and a value of 0 to a low stress level; values near 50 or increase in value > delta 10 correspond to the stress level which is known to reflect requirement for rescue analgesia. The applicability of SPI- guided deep sedation regimen in colonoscopic procedures has not been previously studied. Additionally, depth of sedation markedly influences the nociception-antinociception balance so its monitoring also proved useful in procedures performed under deep sedation. Therefore, we aim to investigate if both SPI-guided fentanyl administration alongside with State Entropy guided propofol aministration (Adequacy of Anaesthesia monitoring) versus State Entropy guided propofol aministration alongside with fentanyl titration based on haemodynamic parametres versus fentanyl titration based on haemodynamic parametres only influence both patients' or operator's satisfaction from anaesthetic management. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03922815
Study type Interventional
Source Medical University of Silesia
Contact
Status Completed
Phase N/A
Start date September 1, 2019
Completion date January 31, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00153751 - The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS) Phase 2
Completed NCT01176227 - Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) Phase 1/Phase 2
Not yet recruiting NCT06271538 - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Phase 4
Completed NCT01887834 - Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome Phase 1/Phase 2
Completed NCT00130741 - Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS) Phase 1
Completed NCT01072903 - The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS) N/A
Active, not recruiting NCT01028898 - Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome N/A
Recruiting NCT03854422 - For Easy, Fast and Comfortable Colonoscopy, Which Position N/A
Completed NCT02551029 - fMRI and Visceral Perception Upon Capsaicin Infusion N/A
Completed NCT02716285 - Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery Phase 3
Completed NCT05340400 - The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
Completed NCT00189033 - Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre? N/A